In vitro growth inhibitory activity of Medicines for Malaria Venture pathogen box compounds against Leishmania aethiopica

被引：0
|
作者：
Markos Tadele
Solomon M. Abay
Peter Asaga
Eyasu Makonnen
Asrat Hailu
机构：
[1] Ethiopian Institute of Agricultural Research,Animal Health Research Program
[2] College of Health Sciences,Department of Pharmacology and Clinical Pharmacy
[3] Addis Ababa University,Institute of Human Virology
[4] University Freiburg Medical Centre,Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT Africa)
[5] College of Health Sciences,Department of Microbiology, Immunology and Parasitology
[6] Addis Ababa University,undefined
[7] College of Health Sciences,undefined
[8] Addis Ababa University,undefined
来源：
BMC Pharmacology and Toxicology | / 22卷
关键词：
Cutaneous leishmaniasis; Pathogen box;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Novel Antifungal Compounds Discovered in Medicines for Malaria Venture's Malaria Box
    Jung, Eric H.
    Meyers, David J.
    Bosch, Jurgen
    Casadevall, Arturo
    MSPHERE, 2018, 3 (02):
  • [12] In vivo antibabesial activity and bioinformatic analysis of compounds derived from the Medicines for Malaria Venture box against Babesia microti
    Rizk, Mohamed Abdo
    El-Sayed, Shimaa Abd El-Salam
    Eltaysh, Rasha
    Igarashi, Ikuo
    MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2022, 247
  • [13] Medicines for Malaria Venture Pandemic Box In Vitro Screening Identifies Compounds Highly Active against the Tachyzoite Stage of Toxoplasma gondii
    dos Santos, Mike
    Costa, Andreia Luiza Oliveira
    Vaz, Guilherme Henrique de Souza
    de Souza, Gabriela Carolina Alves
    Vitor, Ricardo Wagner de Almeida
    Martins-Duarte, Erica S.
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2023, 8 (12)
  • [14] In Vitro Screening of the Open-Source Medicines for Malaria Venture Malaria Box Reveals Novel Compounds with Profound Activities against Theileria annulata Schizonts
    Hostettler, Isabel
    Mueller, Joachim
    Hemphill, Andrew
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (06) : 3301 - 3308
  • [15] Identification of Anti-staphylococcal and Anti-bio film Compounds by Repurposing the Medicines for Malaria Venture Pathogen Box
    Bhandari, Vasundhra
    Chakraborty, Shalini
    Brahma, Umarani
    Sharma, Paresh
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2018, 8
  • [16] Temporal and Wash-Out Studies Identify Medicines for Malaria Venture Pathogen Box Compounds with Fast-Acting Activity against Both Trypanosoma cruzi and Trypanosoma brucei
    Sykes, Melissa L.
    Kennedy, Emily K.
    Read, Kevin D.
    Kaiser, Marcel
    Avery, Vicky M.
    MICROORGANISMS, 2022, 10 (07)
  • [17] Compounds from the Medicines for Malaria Venture Box Inhibit In Vitro Growth of Babesia divergens, a Blood-Borne Parasite of Veterinary and Zoonotic Importance
    Rizk, Mohamed Abdo
    El-Sayed, Shimaa Abd El-Salam
    Alkhoudary, Mahmoud S.
    Alsharif, Khalaf F.
    Abdel-Daim, Mohamed M.
    Igarashi, Ikuo
    MOLECULES, 2021, 26 (23):
  • [18] Medicines for Malaria Venture COVID Box: a source for repurposing drugs with antifungal activity against human pathogenic fungi
    Almeida-Paes, Rodrigo
    de Andrade, Iara Bastos
    Mesquita Ramos, Mariana Lucy
    de Araujo Rodrigues, Marcus Vinicius
    do Nascimento, Vinicius Alves
    Bernardes-Engemann, Andrea Reis
    Frases, Susana
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2021, 116
  • [19] Screening a repurposing library, the Medicines for Malaria Venture Stasis Box against Schistosoma mansoni
    Pasche, Valerian
    Laleu, Benoit
    Keiser, Jennifer
    PARASITES & VECTORS, 2018, 11
  • [20] Screening a repurposing library, the Medicines for Malaria Venture Stasis Box, against Schistosoma mansoni
    Valérian Pasche
    Benoît Laleu
    Jennifer Keiser
    Parasites & Vectors, 11
12345